Table 1 Baseline characteristics of included patients
Characteristics | Iron dextran | Iron sucrose | P |
|---|---|---|---|
N = 73 | N = 70 | ||
Female sex (%) | 45 (61.6) | 52 (74.3) | 0.112 |
Age, years (sd) | 70 (17.6) | 66 (17.4) | 0.872 |
IV iron indication [n(%)] | |||
Pre-operative | |||
Cardiovascular surgery | 18 (25) | 14 (20) | |
Gastrointestinal surgery | 10 (14) | 8 (11) | |
Orthopedic surgery | 32 (44) | 36 (51) | |
Other surgeries | 1 (1) | 1 (1) | |
Bleeding | |||
Menorrhagia | 2 (3) | 2 (3) | |
Acute GI bleed | 4 (5) | 5 (5) | |
Chronic GI Bleed | 3 (5) | 1 (3) | |
Other | |||
Malignancy | 2 (3) | 2 (3) | |
Indication not available | 1 (2) | 1 (3) | |
Other characteristics [n(%)] | |||
Chronic kidney disease | 7 (10) | 2 (3) | 0.167 |
Previous treatment [n(%)] (available data) | 68 | 57 | |
PO iron | 53 (73) | 50 (71) | |
IM iron | 3 (4) | 0 (0) | |
Erythropoietin (EPO) | 2 (3) | 1 (2) | |
Both iron & EPO | 33 (45) | 30 (43) | |
None | 10 (14) | 6 (4) | |